Pay in 4 interest-free payments of $6.62 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
Dysesthesia: A New Signal for Retatrutide The TRIUMPH-4 Phase 3 trial revealed an unexpected finding: dysesthesia (abnormal touch sensations where normal sensations feel unusual or painful) in 20.9% of participants on 12 mg and 8.8% on 9 mg, compared to 0.7% on placebo (BioSpace, Dec 2025)
Benefits of Tirzepatide for Weight Loss Significant Weight Loss: Clinical studies show that individuals using Tirzepatide can lose up to 15-20% of their body weight
Most patients find that any initial discomfort is manageable and improves significantly after the first 12 weeks, with the therapeutic benefits becoming more apparent over the following months
The study identified the liver as a key source of GDF15 [145]
It is recommended to use at night.) Preservation and storage: Store in light-resistant and hermetic container
However, findings are not uniformly consistent across all populations and biomarkers
US$ 29.66
US$ 20.82
US$ 29.92
US$ 26.01
US$ 21.63
US$ 26.91
US$ 22.19
US$ 21.59
US$ 23.43
